does glp 1 go bad My GLP-1 Medication Really Expire? Exploring the Side Effects of

Weight regain and cardiometabolic effects after withdrawal of semaglutide

An analysis of the FDA Adverse Event Reporting System (collecting worldwide adverse events) identified an increased reporting odds ratio for alopecia with semaglutide and tirzepatide, while no significant increase was observed for liraglutide, dulaglutide, exenatide, or lixisenatide [81]

and outcomes: the primary outcome was the BMI reduction, mean days with headache, papilledema, visual disturbances and refractory or nonresponsive IIH

This content does not substitute for consultation with a licensed physician, nurse practitioner, or other qualified healthcare professional